remission

Read news on remission with our app.

Read more in the app

Two People With Severe Autoimmune Disease in Remission After Immune 'Reset'

New targeted radiopharmaceutical therapy induces remission in pancreatic cancer model - EurekAlert!

CAR-T therapy drives remission in patient with three autoimmune diseases - EurekAlert!

Woman With 3 Autoimmune Diseases Enters Remission After Immune 'Reset'

Researchers identify why some people with HIV achieve remission after antibody treatment - EurekAlert!

Remission achievable for 1 in 3 Indian diabetics through intensive app-based lifestyle program - EurekAlert!

First clinical practice guideline on lifestyle interventions for treatment and remission of type 2 diabetes and prediabetes in adults is published - EurekAlert!

Digital PCR can reliably determine if chronic myeloid leukemia patients in remission can successfully discontinue drug treatment

Breakthrough in childhood brain cancer research could heal treatment-resistant tumors, keep them in remission

Breakthrough in childhood brain cancer research could heal treatment-resistant tumors, keep them in remission - EurekAlert

How breast cancer cells survive in bone marrow after remission

Psychedelics proven to reduce depression. Clinical trial shows 100% of participants responsive to treatment, 71% in remission after 12 months and only 2 doses.

Initiating HIV Treatment Within 4 Weeks of Infection May Lead to Remission, Bypassing Continuous Antiviral Use and Side Effects

Soups And Shakes Diet Can Put Type 2 Diabetes Into Remission, Study Finds

Optimum protection against diabetes: Weight loss plus remission of prediabetes

79% of Crohn's disease patients in remission after early intervention

HIV: Early treatment, one key to remission

Guardian of Remission: Vaccine Shows Success in Preventing Cancer Relapse

CAR-T therapy forces autoimmune diseases into remission. All 15 participants, who either had SLE, systemic sclerosis or idiopathic inflammatory myositis, have remained disease-free or nearly so since their treatment. The first participants were treated more than two years ago.

Cybin Reports Positive Topline Data from Phase 2 Study of CYB003 in Major Depressive Disorder with 79% of Patients in Remission after Two 12mg Doses